FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2943070957> ?p ?o ?g. }

• W2943070957 abstract "Respiratory syncytial virus (RSV) is a leading cause of morbidity and mortality in human infants. Bovine RSV infection of neonatal calves is pathologically and immunologically similar to RSV infection in infants, and is therefore a useful preclinical model for testing novel therapeutics. Treatment of severe RSV bronchiolitis relies on supportive care and may include use of bronchodilators and inhaled or systemic corticosteroids. Interleukin-17A (IL-17) is an inflammatory cytokine that plays an important role in neutrophil recruitment and activation. IL-17 is increased in children and rodents with severe RSV infection; and in calves with severe BRSV infection. It is currently unclear if IL-17 and Th17 immunity is beneficial or detrimental to the host during RSV infection. Digoxin was recently identified to selectively inhibit IL-17 production by antagonizing its transcription factor, retinoid-related orphan receptor γ t (RORγt). Digoxin inhibits RORγt binding to IL-17 and Th17 associated genes, and suppresses IL-17 production in vitro in human and murine leukocytes and in vivo in rodent models of autoimmune disease. We demonstrate here that in vitro and in vivo digoxin treatment also inhibits IL-17 production by bovine leukocytes. To determine the role of IL-17 in primary RSV infection, calves were treated prophylactically with digoxin and infected with BRSV. Digoxin treated calves demonstrated reduced signs of clinical illness after BRSV infection, and reduced lung pathology compared to untreated control calves. Digoxin treatment did not adversely affect virus shedding or lung viral burden, but had a significant impact on pulmonary inflammatory cytokine expression on day 10 post infection. Together, our results suggest that exacerbated expression of IL-17 has a negative impact on RSV disease, and that development of specific therapies targeting Th17 immunity may be a promising strategy to improve disease outcome during severe RSV infection." @default.
• W2943070957 created "2019-05-09" @default.
• W2943070957 creator A5037198982 @default.
• W2943070957 creator A5080616173 @default.
• W2943070957 creator A5083418828 @default.
• W2943070957 date "2019-03-25" @default.
• W2943070957 modified "2023-10-07" @default.
• W2943070957 title "Prophylactic digoxin treatment reduces IL-17 production in vivo in the neonatal calf and moderates RSV-associated disease" @default.
• W2943070957 cites W1544109250 @default.
• W2943070957 cites W1843142289 @default.
• W2943070957 cites W1968362155 @default.
• W2943070957 cites W1968715103 @default.
• W2943070957 cites W1972815843 @default.
• W2943070957 cites W1973221350 @default.
• W2943070957 cites W1979400047 @default.
• W2943070957 cites W1982558102 @default.
• W2943070957 cites W1982948902 @default.
• W2943070957 cites W1984976319 @default.
• W2943070957 cites W1986095162 @default.
• W2943070957 cites W1989959574 @default.
• W2943070957 cites W1990121691 @default.
• W2943070957 cites W1991730258 @default.
• W2943070957 cites W1993706997 @default.
• W2943070957 cites W2002156365 @default.
• W2943070957 cites W2008173883 @default.
• W2943070957 cites W2009787072 @default.
• W2943070957 cites W2010589224 @default.
• W2943070957 cites W2011512442 @default.
• W2943070957 cites W2012996843 @default.
• W2943070957 cites W2014913358 @default.
• W2943070957 cites W2019970499 @default.
• W2943070957 cites W2036291264 @default.
• W2943070957 cites W2045412178 @default.
• W2943070957 cites W2058436765 @default.
• W2943070957 cites W2060616257 @default.
• W2943070957 cites W2066243349 @default.
• W2943070957 cites W2067124427 @default.
• W2943070957 cites W2068379760 @default.
• W2943070957 cites W2081865266 @default.
• W2943070957 cites W2084765237 @default.
• W2943070957 cites W2087264630 @default.
• W2943070957 cites W2094285989 @default.
• W2943070957 cites W2103007849 @default.
• W2943070957 cites W2107277218 @default.
• W2943070957 cites W2109666345 @default.
• W2943070957 cites W2113811867 @default.
• W2943070957 cites W2120949068 @default.
• W2943070957 cites W2126355151 @default.
• W2943070957 cites W2127940318 @default.
• W2943070957 cites W2128111454 @default.
• W2943070957 cites W2133052414 @default.
• W2943070957 cites W2137323830 @default.
• W2943070957 cites W2141094117 @default.
• W2943070957 cites W2142566701 @default.
• W2943070957 cites W2143978066 @default.
• W2943070957 cites W2149167149 @default.
• W2943070957 cites W2149574924 @default.
• W2943070957 cites W2150309776 @default.
• W2943070957 cites W2157580055 @default.
• W2943070957 cites W2157827810 @default.
• W2943070957 cites W2168698150 @default.
• W2943070957 cites W2192080449 @default.
• W2943070957 cites W2208851958 @default.
• W2943070957 cites W2274347469 @default.
• W2943070957 cites W2288945704 @default.
• W2943070957 cites W2322654587 @default.
• W2943070957 cites W2323926031 @default.
• W2943070957 cites W2409769602 @default.
• W2943070957 cites W2415646315 @default.
• W2943070957 cites W2490411270 @default.
• W2943070957 cites W2586234859 @default.
• W2943070957 cites W2600902542 @default.
• W2943070957 cites W2805048774 @default.
• W2943070957 cites W905194300 @default.
• W2943070957 doi "https://doi.org/10.1371/journal.pone.0214407" @default.
• W2943070957 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6433258" @default.
• W2943070957 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30908540" @default.
• W2943070957 hasPublicationYear "2019" @default.
• W2943070957 type Work @default.
• W2943070957 sameAs 2943070957 @default.
• W2943070957 citedByCount "8" @default.
• W2943070957 countsByYear W29430709572020 @default.
• W2943070957 countsByYear W29430709572021 @default.
• W2943070957 countsByYear W29430709572022 @default.
• W2943070957 crossrefType "journal-article" @default.
• W2943070957 hasAuthorship W2943070957A5037198982 @default.
• W2943070957 hasAuthorship W2943070957A5080616173 @default.
• W2943070957 hasAuthorship W2943070957A5083418828 @default.
• W2943070957 hasBestOaLocation W29430709571 @default.
• W2943070957 hasConcept C11988809 @default.
• W2943070957 hasConcept C126322002 @default.
• W2943070957 hasConcept C150903083 @default.
• W2943070957 hasConcept C203014093 @default.
• W2943070957 hasConcept C207001950 @default.
• W2943070957 hasConcept C2522874641 @default.
• W2943070957 hasConcept C26291073 @default.
• W2943070957 hasConcept C2777707475 @default.
• W2943070957 hasConcept C2778198053 @default.
• W2943070957 hasConcept C2778690821 @default.
• W2943070957 hasConcept C2778821649 @default.

• next